Generative AI-enabled neoantigen vaccine engineering: From tumor antigen discovery to personalized construct design and translational validation.
- DOI
- 10.1016/j.biotechadv.2026.109028
- Published
- 2026 Sep 1
- Container
- Biotechnology advances
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biotechadv.2026.109028,
title = {Generative AI-enabled neoantigen vaccine engineering: From tumor antigen discovery to personalized construct design and translational validation.},
author = {Hu X and Liu X and Wang T and Liu X and Yang G and Huang P and Xu H},
year = {2026},
journal = {Biotechnology advances},
doi = {10.1016/j.biotechadv.2026.109028},
url = {https://doi.org/10.1016/j.biotechadv.2026.109028}
}RIS
TY - JOUR TI - Generative AI-enabled neoantigen vaccine engineering: From tumor antigen discovery to personalized construct design and translational validation. AU - Hu X AU - Liu X AU - Wang T AU - Liu X AU - Yang G AU - Huang P AU - Xu H PY - 2026 JO - Biotechnology advances DO - 10.1016/j.biotechadv.2026.109028 UR - https://doi.org/10.1016/j.biotechadv.2026.109028 ER -
APA
X, H., X, L., T, W., X, L., G, Y., P, H., & H, X. (2026). Generative AI-enabled neoantigen vaccine engineering: From tumor antigen discovery to personalized construct design and translational validation.. Biotechnology advances. https://doi.org/10.1016/j.biotechadv.2026.109028
Source records
- pubmed · retrieved 2026-09-25T19:09:26.142Z